SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is trending after the closing of its AI licensing partnership in Africa, establishing Skye Africa Intelligence. The community is actively discussing the strong potential for a short squeeze, citing the stock's low float, high cost-to-borrow, and increasing short interest.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending after its HLP004 Phase 2 results for Generalized Anxiety Disorder led to a significant stock sell-off, prompting community discussion over the data's efficacy nuances and ironic jokes about the company's ticker symbol, "$HELP." Investors are debating if the drop is an overreaction typical of biotech or justified by data concerns, with many viewing it as a buying opportunity.

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc

Nutex Health is trending following its Q4 earnings, which presented a revenue miss that management clarified with adjustments showing substantial annual growth and robust cash flow, alongside a new $25M share repurchase program. The community is actively debating these financial nuances and largely dismissing a new short report from Capybara Research as an unsubstantiated effort by short sellers to manipulate sentiment.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending after reporting strong quarterly results and significantly raising its future revenue guidance, propelled by robust AI and data center demand. This has sparked widespread optimism among bulls, who anticipate further upside and analyst upgrades, although some in the community express caution regarding the sustainability of the rally.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending following its earnings report, which, despite mixed profitability, triggered positive sentiment in Hong Kong due to a reaffirmed dividend and share buyback, amid ongoing community debate about the company's deep value within a recovering Chinese tech sector.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending after a mixed earnings report that included a revenue beat, an EPS miss, and the announcement of CEO Doug Ingram's retirement, prompting community discussions about potential M&A and future leadership. Investors are also keenly anticipating upcoming Q1 data readouts for key pipeline assets like DM1 and FSHD, alongside ongoing debate over the impact of a potentially more streamlined regulatory environment for rare disease gene therapies on the company's valuation.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros Discovery is trending amid an intense bidding war, as its board deemed Paramount Skydance's revised offer "superior," prompting a four-day window for Netflix to submit a counter-bid. The community is heavily discussing the significant debt burden this acquisition could place on Paramount Skydance, contrasting it with Netflix's potential to walk away with a substantial breakup fee and its impact on the future streaming landscape.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is witnessing a rapid rebound, with its core holdings Samsung and SK Hynix leading a significant surge in the KOSPI index. Community discussion highlights that strong fundamentals in the AI-driven memory chip supercycle are overshadowing recent geopolitical concerns, positioning South Korean tech as an attractive and undervalued opportunity.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne (TER) initially rallied significantly on a strong Q4 earnings beat and optimistic guidance, propelled by surging AI-driven demand in its semiconductor test and robotics divisions. However, the market is now reacting to cautious commentary during the post-earnings conference call, leading to a notable pullback despite the strong underlying AI tailwinds that continue to fuel community discussion.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending amidst sharp investor debate following its recent earnings report and reiterated conservative 2026 guidance, which many view as significantly undervaluing its hyper-growth revenue and strong pipeline. Despite widespread frustration over persistent stock price declines, the initiation of a $75 million share buyback and upcoming catalysts like Rezzayo Phase 3 data are key talking points, fueling arguments about the company's true value and future potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bet on These Japanese ETFs as Nikkei Soars to Record High

Japan's Nikkei 225 hits a record as Sanae Takaichi's election win fuels stimulus hopes, lifting investor appetite for Japanese ETFs like EWJ.

Japan ETFs to Shine as BOJ Upgrades Economic Growth Forecast

EWJ and other Japan ETFs gain appeal as the BOJ lifts growth forecasts to 0.9% for FY26, spotlighting diversified exposure to a reviving economy.

4 Top-Ranked ETF Areas That Beat the Market in 2025

Top-ranked ETF areas that beat SPY in 2025 included semiconductors, Japan, financials and pharma. Winning ETFs were FTXL, EWJV, KBWB and IHE.



Worried About US Market Volatility? Explore These Japanese ETFs

Keep Japanese ETFs like EWJ, DXJ, and EWJV in your watchlist as investors pivot from volatile U.S. markets to Japan's surging equities.  

The Zacks Analyst Blog Highlights FJP, EWJV, DFJ, SCJ, FLJH and SPY

Buffett's bigger bets on Mitsubishi and Mitsui lift Japan's trading houses, with ETFs like FJP, EWJV, DFJ, SCJ and FLJH topping SPY.

Buffett Boosts Stakes in Japan: ETFs to Play

Berkshire's higher stakes in Mitsubishi and Mitsui spark a rally in Japan's trading houses. ETFs like FJP, EWJV, DFJ, SCJ, FLJH are likely to benefit.

Japan’s manufacturing activity shrank yet again in August, with the Trump administration’s tariffs affecting demand.The S&amp;P Global flash Japan Manufacturing Purchasing Managers' Index (PMI) came in at 49.9, higher than the 48.9 seen in July, but still came in below 50, which separates contraction from growth.“This suggests the recovery in manufacturing output may be hard to sustain unless we see an improvement in sales in the near term,” said Annabel Fiddes, Economics Associate Director at S&amp;P Global Market Intelligence. Foreign demand for Japanese goods and services also slipped for the fifth month in a row, with both factories and service providers stating a solid drop in new export work.Retail sentiment on Stocktwits about the <a href="https://stocktwits.com/symbol/EWJ">iShares MSCI Japan ETF</a> (EWJ) was in the ‘bullish’ territory at the time of writing.The report said that average input prices faced by private sector firms in Japan rose at a sharper rate in August. However, the growth remained softer than the average seen over the first half of 2025.Official data showed on Wednesday that Japan’s exports slipped 2.6% in July, compared to a year earlier, as U.S. President Donald Trump’s tariffs continued to hit global trade. While Japan has negotiated a lower 15% tariff rate for its goods compared to the 25% proposed by Washington, it will take at least a few weeks before the Trump administration prepares written documents for their implementation.The August manufacturing activity report showed that the selling price did not rise as much as costs. “Intense market competition and requests from clients for discounts had dampened overall pricing power. Notably, selling prices increased at the softest rate since last October, to suggest a stronger squeeze on operating margins," Fiddes noted.However, the composite PMI increased to 51.9 in August from 51.6 in July, aided by robust growth in the services industry.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/oil-prices-tick-up-on-strong-us-consumption-data/chsSkWpRdLg">Oil Prices Tick Up On Strong US Consumption Data; Traders Eye Ukraine Talks, Jackson Hole Conference</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A worker washes a large ice block while he inspects the production line at the Honda Reizo Co. factory on July 28, 2025 in Taishi, Japan. 

Japan’s Manufacturing Activity Contracts Again As Export Demand Stutters Amid Trump Tariffs, S&P Survey Shows 

The S&P Global flash Japan Manufacturing Purchasing Managers' Index (PMI) came in at 49.9, higher than the 48.9 seen in July, but still came in below 50, which separates contraction from growth.

EWJV
iShares MSCI Japan Value ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest EWJV News

EWJViShares MSCI Japan Value ETF